Dear Sir or Madam:
Please find attached a recommendation from Opt-e-scrip, Inc. for research priorities for the Medicare Prescription Drug Benefit. Attachments include the recommendation and supporting rationale, a JAMA article in support of the recommendation, a picture of the technology described in the document, and an example of an anonymous patient report recently used by a physician for making a treatment decision.
We would like to thank HHS for the opportunity to submit this reccommendation.
Sincerely,
Frederic Huser
Chairman & CEO
Opt-e-scrip, Inc.
973-699-3843 (C)